Open Orphan Plc (LON:ORPH – Get Free Report)’s share price rose 5.3% on Tuesday . The stock traded as high as GBX 10.38 ($0.14) and last traded at GBX 10 ($0.13). Approximately 652,639 shares were traded during mid-day trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.13).
Open Orphan Price Performance
The company has a market cap of £67.09 million and a price-to-earnings ratio of -25.30. The company has a quick ratio of 1.16, a current ratio of 1.19 and a debt-to-equity ratio of 10.88. The company’s fifty day moving average price is GBX 10 and its two-hundred day moving average price is GBX 10.
About Open Orphan
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Recommended Stories
- Five stocks we like better than Open Orphan
- 3 Small Caps With Big Return Potential
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Why is the Ex-Dividend Date Significant to Investors?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Invest in Small Cap Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.